ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 118218 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 118218; 2) Community: the network communities that were significantly associated with the response to NSC 118218; 3) Molecule: the relationships between components within communities and NSC 118218; 4) MDR: the compounds that were significantly associated with the NSC 118218.

NSC Compound Enrichment Correlation
NSC 292816 1-Butanone, 1,1'-(9-ethyl-9H-carbazole-3,6-diyl)bis[4-(dimethylamino)-, (E)-2-butenedioate (1:1) 0.000568922785167321 0.068098948
NSC 375162 Imidazo[1,2-a]pyridine-6-carboxaldehyde, 2-[4-[[(4,5-dihydro-1H-imidazol-2-yl)hydrazono]methyl]phenyl]-, (4,5-dihydro-1H-imidazol-2-yl)hydrazone, dihydroiodide 0.000568922785167321 0.14462667
NSC 697726 RH1 0.000568922785167321 0.36705374
NSC 145668 Cyclocytidine hydrochloride 0.000602374785885765 0.45389422
NSC 49689 Null 0.000602374785885765 0.11422187
NSC 606985 Camptothecin Derivative 0.000602374785885765 0.27980426
NSC 613327 Gemcitabine Y 0.000602374785885765 0.43954909
NSC 618939 Camptothecin Derivative 0.000602374785885765 0.27861157
NSC 643001 3'O-phosphono-(Z)-combretastatin A-4, ammonium salt, hydrate [10:15:4] 0.000602374785885765 0.097145593
NSC 670664 Null 0.000602374785885765 0.030580496
Total:108  Current:3    [First] [Prev] [Next] [Last]